Evidence map›Paper›PMID 12411479›Full record

ArticleThe EMBO journal2002

Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling.

Tilman Brummer, Peter E Shaw, Michael Reth, Yukiko Misawa

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Calcineurin increases glucose activation of ERK1/2 by reversing negative feedback.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tilman BrummerDepartment of Molecular Immunology, Biology III, University of Freiburg and Max-Planck-Institute for Immunobiology, Stuebeweg 51, Germany.
Peter E Shaw
Michael Reth
Yukiko Misawa
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engagement of the B-cell antigen receptor (BCR) leads to activation of the Raf-MEK-ERK pathway and Raf kinases play an important role in the modulation of ERK activity. B lymphocytes express two Raf isoforms, Raf-1 and B-Raf. Using an inducible deletion system in DT40 cells, the contribution of Raf-1 and B-Raf to BCR signalling was dissected. Loss of Raf-1 has no effect on BCR-mediated ERK activation, whereas B-Raf-deficient DT40 cells display a reduced basal ERK activity as well as a shortened BCR-mediated ERK activation. The Raf-1/B-Raf double deficient DT40 cells show an almost complete block both in ERK activation and in the induction of the immediate early gene products c-Fos and Egr-1. In contrast, BCR-mediated activation of nuclear factor of activated T cells (NFAT) relies predominantly on B-Raf. Furthermore, complementation of Raf-1/B-Raf double deficient cells with various Raf mutants demonstrates a requirement for Ras-GTP binding in BCR-mediated activation of both Raf isoforms and also reveals the important role of the S259 residue for the regulation of Raf-1. Our study shows that BCR-mediated ERK activation involves a cooperation of both B-Raf and Raf-1, which are activated specifically in a temporally distinct manner.

Indexed as

Gene DeletionNuclear ProteinsAnimalsB-LymphocytesCell LineChickensDNA-Binding ProteinsEnzyme ActivationGene Expression RegulationMitogen-Activated Protein KinasesMutagenesisNFATC Transcription FactorsProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-rafReceptors, Antigen, B-CellDNA-Binding ProteinsMitogen-Activated Protein KinasesNFATC Transcription FactorsNuclear ProteinsProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-rafReceptors, Antigen, B-CellTranscription Factors

Identifiers

PMID12411479
PMCPMC131085
OpenAlexW2057283586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.